Form 8-K · Current report
KeyCorp 8-K, filed Sep 14, 2026
- Filed
- CIK
- 0000091576
- Accession no.
- 0001628280-26-061680
Summary
KeyCorp raised its full-year 2026 outlook at the Barclays Global Financial Services Conference, with Chief Financial Officer Clark Khayat presenting guidance for revenue up about 8%, net interest income up 9–11%, and noninterest income up 4–5% versus 2025 baselines. The company also guided to average loans up 4–5%, a 4Q net interest margin exit rate of 3.00–3.05%, and a CET1 ratio of 3.25%+ above regulatory minimums.
Key points
- KeyCorp's FY2026 revenue outlook was increased to up ~8% from a prior range of up 7–8% on an operating basis.
- Noninterest income guidance rose to up 4–5% (previously up 3–4%), or up 6–7% on an adjusted basis.
- Adjusted noninterest expense guidance is up ~4% (previously up 3–4%), with net charge-offs to average loans of 40–45 basis points.
- Presentation slides were furnished under Item 7.01 and posted to key.com/ir, with a live webcast and later recording available there.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 7.01 Regulation FD Disclosure. KeyCorp will review its performance, strategy, and outlook at the Barclays Global Financial Services Conference on Monday, September 14, 2026. A copy of the slides forming the basis of the presentation is attached hereto as Exhibit 99.1 and has been posted on KeyCorp’s website (www.key.com/ir) in connection with the conference. A live audio webcast will also be available on the day of the conference at www.key.com/ir. A recording will also be available at www.key.com/ir after the event. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.